Tizanidine Tablet
Product Images NDC 64980-658

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 64980-658). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3edde2f7 87aa 4ae9 Af8a Ddb012ff4862 01)

FDA Label Image

Image (3edde2f7 87aa 4ae9 Af8a Ddb012ff4862 02)

FDA Label Image

Image (3edde2f7 87aa 4ae9 Af8a Ddb012ff4862 03)

Image (3edde2f7 87aa 4ae9 Af8a Ddb012ff4862 03)
This text provides information on the improvement in Ashworth Score based on different doses of tizanidine over hours post-dose. The comparison is made between 16 mg tizanidine, 8 mg tizanidine, and placebo.*
FDA Label Image

Image (3edde2f7 87aa 4ae9 Af8a Ddb012ff4862 04)

Image (3edde2f7 87aa 4ae9 Af8a Ddb012ff4862 04)
This text discusses the improvement in Ashworth Score using tizanidine at a mean dose of 26.8 mg. The evaluation includes data at the end of titration (Study Week 3), end of maintenance (Study Week 7), and the endpoint (Last Observation Carried Forward).*
FDA Label Image

Image (3edde2f7 87aa 4ae9 Af8a Ddb012ff4862 05)

Image (3edde2f7 87aa 4ae9 Af8a Ddb012ff4862 05)
This text provides important information about Tizanidine tablets, including the dosage per tablet, storage instructions, and manufacturer details. Tizanidine tablets are formulated with 2 mg of tizanidine base per tablet and should not be confused with Zanaflex capsules. The tablets should be stored at a temperature of 25°C with permitted excursions, and should be kept in containers with child-resistant closures. For detailed prescribing information, reference should be made to the package insert. The product is manufactured by Graviti Pharmaceuticals Pvt. Ltd in India and distributed by Rising Pharma Holdings, Inc. in East Brunswick, NJ.*
FDA Label Image

Image (3edde2f7 87aa 4ae9 Af8a Ddb012ff4862 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.